Cardiac Ablation Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Cardiac Ablation Devices Pipeline Products Market Report Overview
Cardiac Ablation Devices are devices that use radiofrequency energy to destroy cardiac tissues which propagate incorrect electrical signals to cause an abnormal heart rhythm. The Cardiac Ablation Devices pipeline market research report provides comprehensive information about the Cardiac Ablation Devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Cardiac Ablation Devices Pipeline Products Market Segmentation by Territories
The key territories with products in the pipeline are the US, China, Europe, Canada, Australia, the Czech Republic, South Korea, and Germany. As of February 2023, the US has the highest number of products in the pipeline out of them all.
Cardiac Ablation Devices Pipeline Products Market Analysis, by Territories, 2023 (%)
For more territory insights into the Cardiac Ablation Devices pipeline products market, download a free report sample
Cardiac Ablation Devices Pipeline Products Market Segmentation by Regulatory Paths
The key regulatory paths followed by the Cardiac Ablation Devices pipeline products market are PMA, NMPA, 510(k), CE, MDL, MDITAC, and TGA. Most of the products follow the PMA pathway to enter the market.
Cardiac Ablation Devices Pipeline Products Market Analysis, by Regulatory Paths, 2023 (%)
For more Cardiac Ablation Devices pipeline products regulatory path insights, download a free report sample
Cardiac Ablation Devices Pipeline Products Market - Competitive Landscape
Some of the leading companies in the Cardiac Ablation Devices pipeline products market are AblaCor Medical Corporation, AccuPulse Medical Technology Co Ltd, Acutus Medical Inc, Adagio Medical Inc., Affera Inc, AFreeze GmbH, AngioDynamics Inc, APT Medical Inc, Arga Medtech SA, and Atrian Medical Ltd.
Acutus Medical Inc (Acutus Medical): Headquartered in Carlsbad, California, USA, Acutus Medical is engaged in providing electrophysiological mapping systems for the treatment of cardiac arrhythmias. Acutus Medical’s electrofunctional mapping systems provides solutions to diagnose and treat atrial fibrillation. The company products enable physicians to visualize CT-quality scan, map real-time dipole density, and identify infected locations causing arrhythmia.
Adagio Medical Inc.: Headquartered in Laguna Hills, California, USA, Adagio Medical is a medical device company that develops innovative cryoablation technologies that create continuous, transmural lesions to treat cardiac arrhythmias.
Affera Inc (Affera): Headquartered in Watertown, Massachusetts, USA, Affera is a medical technology company dedicated to developing innovative solutions for the treatment of cardiac arrhythmia, a prevalent condition affecting millions of patients worldwide.
For more company insights into the Cardiac Ablation Devices pipeline products market, download a free report sample
Cardiac Ablation Devices Pipeline Products Market Report Overview
Key Territories | The US, China, Europe, Canada, Australia, the Czech Republic, South Korea, and Germany |
Key Regulatory Paths | PMA, NMPA, 510(k), CE, MDL, MDITAC, and TGA |
Leading Companies | AblaCor Medical Corporation, AccuPulse Medical Technology Co Ltd, Acutus Medical Inc, Adagio Medical Inc., Affera Inc, AFreeze GmbH, AngioDynamics Inc, APT Medical Inc, Arga Medtech SA, and Atrian Medical Ltd |
Scope
This report provides:
- Extensive coverage of the cardiac ablation devices under development
- Reviews of details of major pipeline products which includes product description, licensing and collaboration details, and other developmental activities
- The report reviews the major players involved in the development of cardiac ablation devices and lists all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage
- Key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with a potentially strong product portfolio and create effective counter strategies to gain a competitive advantage
- Identify and understand important and diverse types of Cardiac Ablation Devices under development
- Develop market-entry and market-expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory, and estimated launch date
AccuPulse Medical Technology Co Ltd
Acutus Medical Inc
Adagio Medical Inc.
Affera Inc
AFreeze GmbH
AngioDynamics Inc
APT Medical Inc
Arga Medtech SA
Atrian Medical Ltd
AtriCure Inc
Axon Therapies Inc
Baylis Medical Company Inc
Biosense Webster Inc
Corfigo Inc
Coridea, LLC
CPSI Biotech
Cryofocus Medtech Shanghai Co Ltd
Epiendoaf Inc
Farapulse Inc
Galaxy Medical Products Inc
Hadassah Medical Center
Hangzhou Nuocheng Medical Technology Co Ltd
Hangzhou Nuomao Medical Technology Co Ltd
Helical Solutions, Inc. (Inactive)
Huifeng Biotechnology (Shanghai) Co Ltd
Insight Lifetech Co Ltd
Japan Lifeline Co Ltd
Johns Hopkins University
Kardium Inc
LuxCath, LLC
Medtronic Plc
National Science and Technology Development Agency
Northwestern University
Pavmed Inc
Shanghai Antec Medical Technology Co Ltd
Shanghai HeartCare Medical Technology Co Ltd
Shanghai Keku Medical Technology Co Ltd
Shanghai Weiqi Medical Equipment Co Ltd
Shanghai Xuanyu Medical Equipment Co Ltd
Sichuan Jinjiang Electronic Science and Technology Co Ltd
Spectranetics Corp
Suzhou Aikemai Medical Technology Co Ltd
Tau Pnu Medical Co., Ltd.
The Chaim Sheba Medical Center
Thermedical Inc
Tianjin Intelligent Health Medical Co Ltd
Toray Medical Co Ltd
Tufts Medical Center
University of California Los Angeles
University of Chicago
University of Iowa
Varian Medical Systems Inc
Virginia Polytechnic Institute and State University
VytronUS Inc
Table of Contents
Frequently asked questions
-
What are the key territories in the Cardiac Ablation Devices pipeline products market?
The US, China, Europe, Canada, Australia, the Czech Republic, South Korea, and Germany are the key territories with products in the pipeline.
-
What are the key regulatory paths of the Cardiac Ablation Devices pipeline products market?
The key regulatory paths followed by the Cardiac Ablation Devices pipeline products market are PMA, NMPA, 510(k), CE, MDL, MDITAC, and TGA.
-
What are the leading companies in the Cardiac Ablation Devices pipeline products market?
Some of the leading companies in the Cardiac Ablation Devices pipeline products market are AblaCor Medical Corporation, AccuPulse Medical Technology Co Ltd, Acutus Medical Inc, Adagio Medical Inc., Affera Inc, AFreeze GmbH, AngioDynamics Inc, APT Medical Inc, Arga Medtech SA, and Atrian Medical Ltd.
-
What are Cardiac Ablation Devices?
Cardiac Ablation Devices are devices that use radiofrequency energy to destroy cardiac tissues which propagate incorrect electrical signals to cause an abnormal heart rhythm.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.